Microvast (MVST) investor relations material

Executive summary

• Achieved record annual revenue of $427.5 million in 2025, up 12.6% year-over-year, with strong growth in EMEA and the U.S., despite regulatory shifts in Korea and customer delays in EMEA.

• Delivered annual gross margin of 28.6%, impacted by a $32.5 million inventory impairment charge on ESS components.

• Reported GAAP net loss of $29.2 million, but achieved non-GAAP adjusted net profit of $13 million and adjusted EBITDA of $44.7 million, a turnaround from the prior year.

• Revenue growth driven by increased sales volume, successful commercialization of new battery technologies, and major capacity expansion at Huzhou Phase 3.2.

• Cash, cash equivalents, and restricted cash increased to $169.2 million at year-end, up from $109.6 million.

Financial highlights

• Full-year revenue rose to $427.5 million from $379.8 million in 2024, a 12.6% increase.

• Gross profit reached $122.1 million; gross margin declined to 28.6% from 31.5% due to inventory impairment.

• Operating expenses dropped to $118.3 million from $238.3 million in 2024, mainly due to lower G&A and R&D costs.

• Non-GAAP adjusted EBITDA improved to $44.7 million from -$44.8 million in 2024.

• Net positive operating cash flow of $75.9 million, up from $2.8 million in 2024.

Outlook and guidance

• Expect continued revenue growth in 2026, with focus on high-margin deliveries, strategic agility amid evolving tariffs, and ramping up Huzhou Phase 3.2 for serial production.

• Priorities include ramping up production, protecting margins, diversifying into high-value markets, and launching new products.

• Targeting serial production at Huzhou Phase 3.2 and pack line operations in Clarksville for U.S. commercial vehicle customers by year-end.

• Pursuing new customer pipelines in EMEA, North America, and APAC, especially in high-barrier segments.